[HTML][HTML] Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch
…, M Kebabonye, M Matsheka, M Mine… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United …
2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United …
Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program
…, T Gaolathe, J Puvimanasinghe, A Avalos, M Mine… - Aids, 2008 - journals.lww.com
Background: Antiretroviral treatment (ART) initiatives have now been established in many
sub-Saharan African countries showing early benefits. To date, few results are available …
sub-Saharan African countries showing early benefits. To date, few results are available …
Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of …
…, T Nkoane, R Ntumy, E Bile, M Mine… - The Pediatric …, 2008 - journals.lww.com
Background: Botswana has high antenatal human immunodeficiency virus (HIV) prevalence
(33.4%). The public health system provides free services for prevention of mother to child …
(33.4%). The public health system provides free services for prevention of mother to child …
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based …
…, A Avalos, B Brenner, T Gaolathe, M Mine… - Antimicrobial agents …, 2006 - Am Soc Microbiol
We analyzed the reverse transcriptase genotypes of human immunodeficiency virus type 1
subtype C viruses isolated from 23 patients in Botswana treated with didanosine-based …
subtype C viruses isolated from 23 patients in Botswana treated with didanosine-based …
Advanced human immunodeficiency virus disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal …
…, AP Steenhoff, Y Mashalla, M Mine… - Clinical infectious …, 2017 - academic.oup.com
Background Botswana has a well-developed antiretroviral therapy (ART) program that
serves as a regional model. With wide ART availability, the burden of advanced human …
serves as a regional model. With wide ART availability, the burden of advanced human …
Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine …
The emergence and spread of transmitted drug resistance (TDR) poses a major threat to the
success of the rapidly expanding antiretroviral treatment (ART) programs in resource-limited …
success of the rapidly expanding antiretroviral treatment (ART) programs in resource-limited …
[HTML][HTML] HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the “test-and-treat” approach to reduce HIV transmission
…, A Campa, S Moyo, E Van Widenfelt, M Mine… - PLoS …, 2010 - journals.plos.org
The first aim of the study is to assess the distribution of HIV-1 RNA levels in subtype C
infection. Among 4,348 drug-naïve HIV-positive individuals participating in clinical studies in …
infection. Among 4,348 drug-naïve HIV-positive individuals participating in clinical studies in …
Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana
TB Leeme, M Mine, K Lechiile, F Mulenga… - HIV …, 2021 - Wiley Online Library
Objectives National guidelines in Botswana recommend baseline CD4 count measurement
and both CD4 and HIV viral load (VL) monitoring post‐antiretroviral therapy (ART) initiation. …
and both CD4 and HIV viral load (VL) monitoring post‐antiretroviral therapy (ART) initiation. …
[HTML][HTML] An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial
…, B Sakyi, E van Widenfelt, K Keapoletswe, M Mine… - PloS one, 2015 - journals.plos.org
Background Less than one-third of HIV-infected pregnant women eligible for combination
antiretroviral therapy (ART) globally initiate treatment prior to delivery, with lack of access to …
antiretroviral therapy (ART) globally initiate treatment prior to delivery, with lack of access to …
Evaluation of a novel semiquantitative cryptococcal antigen lateral flow assay in patients with advanced HIV disease
…, TS Harrison, NP Govender, M Mine - Journal of Clinical …, 2020 - Am Soc Microbiol
Higher cryptococcal antigen (CrAg) titers are strongly associated with mortality risk in
individuals with HIV-associated cryptococcal disease. Rapid tests to quantify CrAg levels may …
individuals with HIV-associated cryptococcal disease. Rapid tests to quantify CrAg levels may …